| POU2F2 antibodies | | | This is a review about POU2F2 antibodies, based on 5 published articles using POU2F2 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited POU2F2 antibody. |
| Santa Cruz Biotechnology search Santa Cruz Biotechnology POU2F2 products | | ih | Santa Cruz OCT.2 (C-20 sc-233, dilution 1:600) antibody was used in immunohistochemistry to study a potential prognostic role of MUM1/IRF4 in classical Hodgkin's lymphoma. to the paper | | chip, emsa, wb | Santa Cruz Biotechnologies rabbit anti-Oct-2 antibody was used in western blot, EMSA and ChIP assay to study the regulation of human 3' Igh hs4 enhancer activity in B cells by synergistic interaction between Oct-2 and NF-kappaB. to the paper | | ih | Santa Cruz Biotechnology polyclonal OCT-2 (sc-233) antibody was used in immunohistochemistry to study OCT-1, OCT-2, and BOB-1/OCA-B expression in normal lymphoid tissue and in T-cell neoplasms. to the paper | | ih | Santa Cruz polyclonal Oct-2 antibody was used in immunohistochemistry to detect Oct-2 expression in human primary mediastinal (thymic) B-cell lymphoma (PMBL). to the paper |
| NOVOCASTRA | | ih | Novocastra POU2F2 antibody was tested in immunohistochemistry by HPA (CAB002513) . to the paper |
| Articles Reviewed | | 1: | Serena Valsami et al. A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4. 2007 | | 2: | Anja Persson et al. A human protein atlas based on antibody proteomics. 2006 | | 3: | Manuel A Sepulveda et al. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells. 2004 | | 4: | Teresa Marafioti et al. Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms. 2003 | | 5: | Stefano A Pileri et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. 2003 |
|